4d Pharma PLC - Leeds, England-based pharmaceutical company - Says it has ordered an immediate suspension of trading in the company's shares on AIM pending a further announcement.
4d Pharma develops live biotherapeutics, defined by the Food & Drug Administration as biological products that contain a live organism.
Current stock price: up 2.8% at 16.30 pence each on Friday
12-month change: down 84%
By Xindi Wei; xindiwei@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
